Weight Watchers to Participate in Upcoming Investor Conferences
Rhea-AI Summary
Weight Watchers (NASDAQ: WW) will participate in investor conferences in January 2026, including the ICR Conference in Orlando on January 12–13 and a virtual fireside chat at the CJS Securities 26th Annual New Ideas for the New Year on January 14 at 11:00 a.m. ET.
The January 14 fireside chat will be available via live audio webcast at corporate.ww.com under Events and Presentations, with a replay accessible for at least 90 days. Weight Watchers said it will host investor meetings during these events.
Weight Watchers described its offering as an integrated, science-backed weight management system for the GLP-1 era, combining clinical interventions, access to GLP-1 medications when clinically appropriate, technology, and coaching. For investor inquiries, contacts were provided.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, WW declined 1.24%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“Weight Watchers” or the “Company”), the global leader in science-backed weight management, today announced that the Company will be participating in the following investor conferences in January:
- January 12-13, 2026: ICR Conference in Orlando, FL. The Company will host meetings with investors throughout the event.
- January 14, 2026: CJS Securities 26th Annual New Ideas for the New Year. The Company will be participating in a virtual fireside chat at 11:00 a.m. ET. The fireside chat will be accessible via live audio webcast on the Company’s corporate website, corporate.ww.com, under Events and Presentations. A replay of the webcast will be available on this site for at least 90 days. The Company will also host meetings with investors.
ABOUT WEIGHT WATCHERS
Weight Watchers is the global leader in science-backed weight management, offering an integrated support system built for the GLP-1 era that combines scientific expertise, medication, cutting-edge technology, and human connection. With more than 60 years of experience, Weight Watchers is the most studied commercial weight management program in the world, delivered through its No. 1 U.S. doctor-recommended weight-loss program. Its holistic, personalized approach also includes U.S.-based clinical interventions and access to GLP-1 medications when clinically appropriate, and a global network of coaches and community support. Since 1963, the company has led with science to deliver its members the personalized support they need to reach and sustain their goals. Members can access these solutions directly, or through Weight Watchers for Business’ full-spectrum platform for employers, health plans, and payers. In a landscape crowded with contradictory advice, isolating apps, and one-size-fits-all solutions, Weight Watchers offers a proven path forward that is rooted in research, grounded in empathy and designed to help every member feel better in their body and live a longer, healthier life. For more information, visit weightwatchers.com.
For investor inquiries, please contact:
John Mills or Anna Kate Heller
WeightWatchers@icrinc.com